In the context of cancer, increased PROX1 expression in tumor-associated lymphatic vessels has been associated with enhanced lymphangiogenesis and lymphatic vessel density, which could provide routes for cancer cell dissemination and lymphatic metastasis. Here, PROX1 is linked to neoplasm.